The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two years rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with marginal zone lymphoma (MZL): Results of a prospective, randomized, multicenter phase 2 study (the StiL NHL7-2008 MAINTAIN trial).
 
Mathias J. Rummel
Honoraria - Roche Pharma AG
Research Funding - Roche Pharma AG
 
Michael Koenigsmann
No Relationships to Disclose
 
Kai Uwe Chow
No Relationships to Disclose
 
Wolfgang Knauf
No Relationships to Disclose
 
Christian A. Lerchenmuller
No Relationships to Disclose
 
Christoph Losem
No Relationships to Disclose
 
Martin Goerner
No Relationships to Disclose
 
Bernd Hertenstein
No Relationships to Disclose
 
Thomas Decker
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis
 
Arnold Ganser
Consulting or Advisory Role - Cellgen; Jazz Pharmaceuticals
 
Tobias Gaska
Research Funding - Gilead Sciences; Janssen-Cilag; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Ipsen
 
Michael Heike
No Relationships to Disclose
 
Elisabeth Lange
No Relationships to Disclose
 
Rudolf Weide
No Relationships to Disclose
 
Wolfgang Willenbacher
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Novartis; Roche; Takeda
Speakers' Bureau - Gilead Sciences
Research Funding - Amgen; Celgene; Janssen; Takeda
 
Alexander Burchardt
No Relationships to Disclose
 
Frank Kauff
No Relationships to Disclose
 
Juergen Barth
Honoraria - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; CSL Behring; Hexal; Johnson & Johnson; Lilly; Medac; Mundipharma; Roche Pharma AG; Takeda
 
Axel Hinke
Honoraria - Roche Pharma AG
 
Richard Greil
Honoraria - Amgen; AstraZeneca; MSD; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Roche Pharma AG
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen; Roche Pharma AG